Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States-Reference-Cited by-同舟云学术

Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States

Published:2013-09 Issue:6 Volume:16 Page:973-986
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Chhatwal Jagpreet,Ferrante Shannon A.,Brass Cliff,El Khoury Antoine C.,Burroughs Margaret,Bacon Bruce,Esteban-Mur Rafael,Elbasha Elamin H.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference51 articles.

1. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

2. Hepatitis C Fact Sheet. Geneva: World Health Organization. Available from: http://www.who.int/mediacentre/factsheets/fs164/en. [Accessed December 8, 2012].

3. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007;Ly;Ann Intern Med,2012

4. The epidemiology of hepatitis C infection in the United States;Rustgi;J Gastroenterol,2007

5. Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis;Camm;J Hepatol,2009

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals;Clinical Gastroenterology and Hepatology;2024-01

2. Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California;The American Journal of Managed Care;2023-10-20

3. Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective;Journal of Managed Care & Specialty Pharmacy;2022-10

4. Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication;Journal of Hepatology;2022-07

5. Cost-Effectiveness of a Core Antigen–Based Rapid Diagnostic Test for Hepatitis C;Value in Health;2022-07